Kontigo Care AB (publ) (KONT.ST)
Uppsala, SE
Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Gambling, a digital application for tackling gambling addiction. Established in 2013, the firm maintains its primary operations in Uppsala, Sweden.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +4.76% | -4.67% | -13.86% | -17.34% | -24.34% | -20.56% | -31.90% | -58.91% | -75.43% | -69.89% | -78.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-02 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%-3.7% Q1'26: +4.3% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%-340.0% Q1'26: +164.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-3.4% Q1'26: -68.6% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-7.3% Q1'26: +3.3% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-6.0% Q1'26: +2.7% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+14.1% Q1'26: -0.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. |
Dec 2027 1 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.08M
est: 1.10M (-1.6%)
|
6.23M
est: 8.60M (-27.5%)
|
13.23M
est: 15.00M (-11.8%)
|
17.62M
est: 32.00M (-45.0%)
|
20.38M
est: 48.00M (-57.5%)
|
24.54M
est: 63.00M (-61.0%)
|
28.44M
est: 29.20M (-2.6%)
|
28.95M
est: 29.00M (-0.2%)
|
30.24M
est: 41.20M (-26.6%)
|
29.13M
est: 29.30M (-0.6%)
|
43.20M
43.20M – 43.20M
+47.4% YoY
|
59.50M
57.50M – 61.50M
+37.7% YoY
|
| EBITDA |
-17.28M
est: 107.0K (-16,244.7%)
|
-11.62M
est: 836.7K (-1,488.3%)
|
-4.07M
est: 1.46M (-379.1%)
|
-945.0K
est: 3.11M (-130.4%)
|
2.20M
est: 4.67M (-52.9%)
|
90.9K
est: 6.13M (-98.5%)
|
4.13M
est: 2.84M (+45.5%)
|
1.79M
est: 2.82M (-36.4%)
|
5.07M
est: 9.79M (-48.2%)
|
3.57M
est: 6.96M (-48.7%)
|
10.26M
10.26M – 10.26M
+47.4% YoY
|
14.13M
13.66M – 14.61M
+37.7% YoY
|
| EBIT |
-19.22M
est: 11.6K (-165,202.6%)
|
-14.02M
est: 91.0K (-15,505.3%)
|
-6.57M
est: 158.7K (-4,239.1%)
|
-1.25M
est: 338.7K (-469.2%)
|
-1.10M
est: 508.0K (-317.3%)
|
-1.11M
est: 666.7K (-265.9%)
|
2.90M
est: 309.0K (+836.8%)
|
620.0K
est: 306.9K (+102.0%)
|
874.0K
est: 282.9K (+209.0%)
|
-2.12M
est: 201.2K (-1,153.4%)
|
296.6K
296.6K – 296.6K
+47.4% YoY
|
408.5K
394.8K – 422.2K
+37.7% YoY
|
| Net Income |
-19.63M
est: -43.32M (+54.7%)
|
-14.37M
est: -21.04M (+31.7%)
|
-6.72M
est: -6.50M (-3.4%)
|
-1.58M
est: 9.28M (-117.0%)
|
-1.28M
est: 21.66M (-105.9%)
|
-1.20M
est: 27.85M (-104.3%)
|
2.90M
|
212.0K
|
775.0K
|
-2.07M
|
—
— – —
|
—
— – —
|
| SGA |
8.34M
est: 992.9K (+740.4%)
|
8.19M
est: 7.76M (+5.5%)
|
7.51M
est: 13.54M (-44.6%)
|
8.08M
est: 28.89M (-72.0%)
|
9.59M
est: 43.33M (-77.9%)
|
10.95M
est: 56.87M (-80.8%)
|
29.16M
est: 26.36M (+10.6%)
|
40.54M
est: 26.18M (+54.9%)
|
35.40M
est: 33.31M (+6.3%)
|
—
est: 23.69M (-100.0%)
|
34.93M
34.93M – 34.93M
+47.4% YoY
|
48.11M
46.49M – 49.73M
+37.7% YoY
|
| EPS |
-1.40
est: -1.40 (+0.0%)
|
-0.79
est: -0.68 (-16.2%)
|
-0.30
est: -0.21 (-42.9%)
|
-0.07
est: 0.30 (-122.8%)
|
-0.06
est: 0.70 (-107.9%)
|
-0.05
est: 0.90 (-105.6%)
|
0.12
|
0.01
|
0.03
|
-0.06
|
—
— – —
|
—
— – —
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Alexander Stendahl | Chief Executive Officer & Director | 2M | male |
| Anja Peters Ohlsson | Consultant | — | female |
| Peter Larsson | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for KONT.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
